BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15965822)

  • 1. [Reducing toxicity of methotrexate with folic acid].
    Harten P
    Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
    Whittle SL; Hughes RA
    Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
    Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
    J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate's efficacy?
    Killeen OG; Gardner-Medwin JM
    Arch Dis Child; 2006 Jun; 91(6):537-8. PubMed ID: 16714734
    [No Abstract]   [Full Text] [Related]  

  • 10. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
    Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
    J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
    Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.
    van Ede AE; Laan RF; Blom HJ; De Abreu RA; van de Putte LB
    Semin Arthritis Rheum; 1998 Apr; 27(5):277-92. PubMed ID: 9572710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
    Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
    J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
    Prey S; Paul C
    Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate supplementation and methotrexate.
    Dijkmans BA
    Br J Rheumatol; 1995 Dec; 34(12):1172-4. PubMed ID: 8608361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
    van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
    Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.
    Bourré-Tessier J; Haraoui B
    J Rheumatol; 2010 Jul; 37(7):1416-21. PubMed ID: 20436072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines.
    Endresen GK; Husby G
    Scand J Rheumatol; 2001; 30(3):129-34. PubMed ID: 11469521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.
    Pincus T
    Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
    Stamp LK; Roberts RL
    Pharmacogenomics; 2011 Oct; 12(10):1449-63. PubMed ID: 22008049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.